Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...

Credit: Dr Salahuddin Kazi, MD, comments on the challenges of diagnosing seronegative rheumatic diseases and discusses a ...

Gout typically occurs in bouts or attacks, before settling with treatment and becoming dormant. But it can reoccur, requiring more acute treatment. A diagnosis of gout is based around the classic ...

Gout typically occurs in bouts or attacks, before settling with treatment and becoming dormant. But it can reoccur, requiring more acute treatment. A diagnosis of gout is based around the classic ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

Hyperuricemia (HU) is a metabolic disorder characterized by elevated uric acid (UA) levels in the bloodstream, commonly diagnosed when UA levels ...

High blood pressure causes everything from heart attacks and strokes to blindness, kidney failure and erectile dysfunction ...

[PubMed: 28122760] About XORTX Therapeutics Inc. XORTX is a pharmaceutical company with three clinically advanced products in development: 1) our lead program XRx-026 program for the treatment of gout ...

Assertio (NASDAQ:ASRT – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Monday. Separately, HC ...

Flaxseed packs omega-3s, fiber and lignans into a tiny package. Discover 7 creative ways to enjoy this nutritional powerhouse and the impressive health benefits ...